BG104855A - New substituted amides, their production and their use - Google Patents
New substituted amides, their production and their useInfo
- Publication number
- BG104855A BG104855A BG104855A BG10485500A BG104855A BG 104855 A BG104855 A BG 104855A BG 104855 A BG104855 A BG 104855A BG 10485500 A BG10485500 A BG 10485500A BG 104855 A BG104855 A BG 104855A
- Authority
- BG
- Bulgaria
- Prior art keywords
- alkyl
- branched
- hydrogen
- unbranched chain
- formula
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 102000005927 Cysteine Proteases Human genes 0.000 abstract 2
- 108010005843 Cysteine Proteases Proteins 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 102000005600 Cathepsins Human genes 0.000 abstract 1
- 108010084457 Cathepsins Proteins 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 108010044467 Isoenzymes Proteins 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000005495 pyridazyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
- Polyamides (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19818614A DE19818614A1 (de) | 1998-04-20 | 1998-04-20 | Neue substituierte Amide, deren Herstellung und Anwendung |
| PCT/EP1999/002618 WO1999054294A1 (de) | 1998-04-20 | 1999-04-19 | Neue substituierte amide, deren herstellung und anwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG104855A true BG104855A (en) | 2001-05-31 |
Family
ID=7865830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG104855A BG104855A (en) | 1998-04-20 | 2000-10-13 | New substituted amides, their production and their use |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6448254B1 (pt) |
| EP (1) | EP1073631A1 (pt) |
| JP (1) | JP2002512221A (pt) |
| KR (1) | KR20010042836A (pt) |
| CN (1) | CN1297432A (pt) |
| AU (1) | AU753402B2 (pt) |
| BG (1) | BG104855A (pt) |
| BR (1) | BR9909775A (pt) |
| CA (1) | CA2328435A1 (pt) |
| DE (1) | DE19818614A1 (pt) |
| HR (1) | HRP20000776A2 (pt) |
| HU (1) | HUP0101624A3 (pt) |
| ID (1) | ID26402A (pt) |
| IL (1) | IL138412A0 (pt) |
| NO (1) | NO20005266L (pt) |
| PL (1) | PL343465A1 (pt) |
| SK (1) | SK13942000A3 (pt) |
| TR (1) | TR200003028T2 (pt) |
| WO (1) | WO1999054294A1 (pt) |
| ZA (1) | ZA200006711B (pt) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6683581B2 (en) * | 2000-12-29 | 2004-01-27 | Bellsouth Intellectual Property Corporation | Antenna alignment devices |
| DE10114762A1 (de) * | 2001-03-26 | 2002-10-02 | Knoll Gmbh | Verwendung von Cysteinprotease-Inhibitoren |
| JP2005504040A (ja) * | 2001-08-03 | 2005-02-10 | スミスクライン ビーチャム コーポレーション | カテプシンＫ阻害剤としてのα−ケトアミド誘導体 |
| WO2003062192A1 (en) * | 2002-01-17 | 2003-07-31 | Smithkline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| CA2505098A1 (en) | 2002-11-12 | 2004-05-27 | Merck & Co., Inc. | Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| GB0228410D0 (en) | 2002-12-05 | 2003-01-08 | Glaxo Group Ltd | Novel Compounds |
| ZA200605587B (en) * | 2003-12-22 | 2008-02-27 | Ajinomoto Kk | Novel phenylalanine derivative |
| US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| RS56873B1 (sr) | 2004-06-24 | 2018-04-30 | Vertex Pharma | Modulatori atp-vezujućih kasetnih transportera |
| CA2634113A1 (en) * | 2005-12-24 | 2007-07-05 | Vertex Pharmaceuticals Incorporated | Quinolin- 4 - one derivatives as modulators of abc transporters |
| EP3219705B1 (en) | 2005-12-28 | 2020-03-11 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of the amorphous form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| NZ599860A (en) | 2006-12-29 | 2013-09-27 | Abbott Gmbh & Co Kg | Carboxamide compounds and their use as calpain inhibitors |
| TWI453019B (zh) * | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
| DE102008027133A1 (de) * | 2008-05-30 | 2009-12-03 | Ls Medcap Gmbh | Vollsynthetisches Albumin-Analogon |
| US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| US12458635B2 (en) | 2008-08-13 | 2025-11-04 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| TWI519530B (zh) * | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途 |
| PT2408750E (pt) | 2009-03-20 | 2015-10-15 | Vertex Pharma | Processo para a produção de modeladores do regulador de condutância transmembranar da fibrose cística |
| US8236798B2 (en) | 2009-05-07 | 2012-08-07 | Abbott Gmbh & Co. Kg | Carboxamide compounds and their use as calpain inhibitors |
| US9051304B2 (en) | 2009-12-22 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
| US8598211B2 (en) * | 2009-12-22 | 2013-12-03 | Abbvie Inc. | Carboxamide compounds and their use as calpain inhibitors IV |
| CA2819087A1 (en) | 2010-12-09 | 2012-06-14 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors v |
| US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| EP2819670A1 (en) | 2012-02-27 | 2015-01-07 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administration thereof |
| WO2013149800A1 (en) | 2012-04-03 | 2013-10-10 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors v |
| US9701639B2 (en) | 2014-10-07 | 2017-07-11 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
| WO2017156071A1 (en) | 2016-03-09 | 2017-09-14 | Blade Therapeutics, Inc. | Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof |
| EP3481835A4 (en) | 2016-07-05 | 2020-02-26 | Blade Therapeutics, Inc. | CALPAIN MODULATORS AND THEIR THERAPEUTIC USES |
| PE20191153A1 (es) | 2016-09-28 | 2019-09-05 | Blade Therapeutics Inc | Moduladores de calpainas y usos terapeuticos de los mismos |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4000204A1 (de) | 1990-01-05 | 1991-07-11 | Steag Ag | Vorrichtung zum dosierten austragen von schuettfaehigem feststoff |
| US5289954A (en) | 1990-01-05 | 1994-03-01 | Steag Aktiengesellschaft | Device for metered removal of flowable solid material |
| JPH06504547A (ja) | 1990-12-28 | 1994-05-26 | ジョージア・テック・リサーチ・コーポレーション | ペプチドケトアミド、ケト酸およびケトエステル |
| EP0564552A1 (en) | 1990-12-28 | 1993-10-13 | Cortex Pharmaceuticals, Inc. | Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| CA2071621C (en) | 1991-06-19 | 1996-08-06 | Ahihiko Hosoda | Aldehyde derivatives |
| JPH09500087A (ja) | 1992-06-24 | 1997-01-07 | コーテックス ファーマシューティカルズ インコーポレイテッド | カルパイン活性の増大に関連した健康障害の抑制及び処置におけるカルパイン阻害剤の使用法 |
| JP2848232B2 (ja) * | 1993-02-19 | 1999-01-20 | 武田薬品工業株式会社 | アルデヒド誘導体 |
| US5674889A (en) | 1993-02-22 | 1997-10-07 | Merck, Sharp & Dohme, Ltd. | Aromatic compounds, compositions containing them and their use in therapy |
| US5541290A (en) | 1993-06-24 | 1996-07-30 | Harbeson; Scott L. | Optically pure calpain inhibitor compounds |
| EP0831920A4 (en) * | 1995-06-06 | 2003-03-19 | Athena Neurosciences Inc | NOVEL CATHEPSIN AND METHODS AND COMPOSITIONS FOR INHIBITING CATHEPSIN |
| AU6977096A (en) | 1995-09-14 | 1997-04-01 | Cephalon, Inc. | Ketomethylene group-containing cysteine and serine protease inhibitors |
| DE69637307T2 (de) | 1995-11-28 | 2008-02-28 | Cephalon, Inc. | Aus d-aminosäuren abgeleitete cystein-und serinproteasehemmer |
-
1998
- 1998-04-20 DE DE19818614A patent/DE19818614A1/de not_active Withdrawn
-
1999
- 1999-04-19 BR BR9909775-3A patent/BR9909775A/pt not_active IP Right Cessation
- 1999-04-19 TR TR2000/03028T patent/TR200003028T2/xx unknown
- 1999-04-19 HR HR20000776A patent/HRP20000776A2/hr not_active Application Discontinuation
- 1999-04-19 EP EP99917996A patent/EP1073631A1/de not_active Withdrawn
- 1999-04-19 HU HU0101624A patent/HUP0101624A3/hu unknown
- 1999-04-19 ID IDW20002112A patent/ID26402A/id unknown
- 1999-04-19 AU AU36071/99A patent/AU753402B2/en not_active Ceased
- 1999-04-19 PL PL99343465A patent/PL343465A1/xx not_active Application Discontinuation
- 1999-04-19 SK SK1394-2000A patent/SK13942000A3/sk unknown
- 1999-04-19 CN CN99805245A patent/CN1297432A/zh active Pending
- 1999-04-19 WO PCT/EP1999/002618 patent/WO1999054294A1/de not_active Ceased
- 1999-04-19 CA CA002328435A patent/CA2328435A1/en not_active Abandoned
- 1999-04-19 IL IL13841299A patent/IL138412A0/xx unknown
- 1999-04-19 KR KR1020007011600A patent/KR20010042836A/ko not_active Withdrawn
- 1999-04-19 JP JP2000544635A patent/JP2002512221A/ja active Pending
- 1999-04-19 US US09/647,677 patent/US6448254B1/en not_active Expired - Fee Related
-
2000
- 2000-10-13 BG BG104855A patent/BG104855A/xx unknown
- 2000-10-19 NO NO20005266A patent/NO20005266L/no not_active Application Discontinuation
- 2000-11-17 ZA ZA200006711A patent/ZA200006711B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU753402B2 (en) | 2002-10-17 |
| BR9909775A (pt) | 2000-12-19 |
| CA2328435A1 (en) | 1999-10-28 |
| DE19818614A1 (de) | 1999-10-21 |
| JP2002512221A (ja) | 2002-04-23 |
| WO1999054294A1 (de) | 1999-10-28 |
| ZA200006711B (en) | 2002-01-09 |
| IL138412A0 (en) | 2001-10-31 |
| PL343465A1 (en) | 2001-08-13 |
| NO20005266D0 (no) | 2000-10-19 |
| NO20005266L (no) | 2000-10-19 |
| EP1073631A1 (de) | 2001-02-07 |
| ID26402A (id) | 2000-12-21 |
| SK13942000A3 (sk) | 2001-05-10 |
| HUP0101624A3 (en) | 2003-02-28 |
| US6448254B1 (en) | 2002-09-10 |
| HUP0101624A2 (hu) | 2001-11-28 |
| HRP20000776A2 (en) | 2001-06-30 |
| TR200003028T2 (tr) | 2001-01-22 |
| KR20010042836A (ko) | 2001-05-25 |
| AU3607199A (en) | 1999-11-08 |
| CN1297432A (zh) | 2001-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG104855A (en) | New substituted amides, their production and their use | |
| BG104856A (en) | Substituted benzamides, their production and their use as cysteine protease inhibitors | |
| PE73799A1 (es) | Inhibidores de proteasas | |
| CA2186764A1 (en) | High-alkaline protease and its use | |
| ATE103632T1 (de) | Enzymatische waschmittelzusammensetzung und verfahren zum stabilisieren der enzyme. | |
| MY119987A (en) | Antithrombotic agents. | |
| EP1360314A4 (en) | CHEMICALLY DEFINED MEDIUM FOR CULTIVATED MAMMALIAN CELLS | |
| MY140680A (en) | Hepatitis c virus inhibitors | |
| CO5611143A2 (es) | Profarmacos de fosfatos de fluorooxindoles | |
| AU7240398A (en) | Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions | |
| HU9204029D0 (en) | Proteolytic enzym inhibitors | |
| MX9804262A (es) | Inhibidores derivados de d-aminoacidos de proteasas de cisteina y serina. | |
| EP0975353A4 (en) | PEPTIDYL-2-AMINO-1HYDROXYALKANESULPHONIC ACIDS AS CYSTEIN PROTEASE INHIBITORS | |
| CA2107804A1 (en) | Newly characterised oxalate oxidase and uses therefor | |
| NZ329532A (en) | Diazepino-indoles as phosphodiesterase iv inhibitors | |
| MY106202A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof. | |
| WO2002094263A3 (en) | Caspase inhibitors and uses thereof | |
| EP0154234A3 (en) | Substituted tyrosil alanine dipeptide amides | |
| CA2155843A1 (en) | Novel urea derivatives, their preparation and use | |
| PL327986A1 (en) | Amidinic inhibitors of proteases | |
| DK0865498T3 (da) | Fremgangsmåde til fremstilling af substituerede arylmælkesyreholdige cyclodepsipeptider med 24 ringatomer | |
| AU2003271811A8 (en) | Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same | |
| SI1377574T1 (pt) | ||
| MX254098B (es) | Composicion detergente liquida con estabilidad mejorada de la enzima alfa-amilasa. | |
| MXPA02007973A (es) | Compuestos de aminoacidos y su uso como inhibidores de nep, ace y ece. |